Irish pharma firm sees Lundbeck’s billion bid as best

The board of the Irish pharmaceutical company Avadel considers Lundbeck’s offer better than a previous bid from an Irish competitor, Alkermes, which has five business days to improve its bid if desired. Lundbeck has offered up to $2.25 billion for Avadel, translating to approximately 14.5...